ReleaseWire Connect

The Dermatology Partnering Terms and Agreementsreport provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals.

LTE has been a driver for major investment for wireless carriers. However, much of the investment is in core network infrastructure that will be used for more than just raw data services. Voice over LTE (VoLTE) represents an opportunity for wireless carriers to improve their competitive position marginally at first, but much more longer term, assuming they properly execute VAS applications such as RCS and open up their APIs.

Synopsis

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.

The Antibiotics Partnering Agreements report provides an understanding and access to the antibiotics partnering deals and agreements entered into by the worlds leading healthcare companies.

The Oncology Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the oncology/cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Summary

Summary

Summary

Summary